Evidence map›Paper›PMID 42897485›Full record

ReviewBMC pediatrics2026

Late-onset cobalamin C defect with a rare MMACHC c.457 C > T variant: a case report and literature review.

Qingmei Huang, Zhenmei Liao, Honghua Li, Xiu Lu, Lingdong Zeng

Abstract readCase ReportsReview
In one paragraph

Review in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qingmei Huang *Department of Pediatrics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China.
Zhenmei Liao *Department of Pediatrics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China.
Honghua LiDepartment of Pediatrics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China.
Xiu LuDepartment of Pediatrics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China. luxiu2011@163.com.
Lingdong ZengDepartment of Pediatrics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China. zenglingdong@sr.gxmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCobalamin C (cblC) defect, also referred to as combined methylmalonic acidemia and homocystinuria, is the most common inborn error of intracellular cobalamin metabolism. Late-onset cblC defect often presents with atypical and heterogeneous manifestations, particularly neuropsychiatric symptoms, which may lead to misdiagnosis and delayed treatment. CASE PRESENTATION: We report a 13-year-old girl with late-onset cblC defect who presented with progressive cognitive impairment, psychiatric and behavioral abnormalities, and motor dysfunction. Because of these atypical manifestations, she was initially misdiagnosed with autoimmune encephalitis. Laboratory evaluation showed markedly elevated plasma total homocysteine, decreased methionine, mildly increased propionylcarnitine with elevated C3/C2 and C3/C0 ratios, and markedly increased urinary methylmalonic acid and methylcitrate. Genetic testing identified compound heterozygous pathogenic variants in the MMACHC gene: c.482G > A (p.Arg161Gln, maternally inherited) and c.457 C > T (p.Arg153Ter), the latter being rarely reported in China. Following treatment with hydroxocobalamin, folate, betaine, and L-carnitine, the patient showed marked biochemical improvement and partial clinical recovery, although residual cognitive impairment and gait disturbance persisted.

conclusionsThis case expands the genotypic spectrum of cblC defect in China and highlights the importance of metabolic screening and genetic testing in children and adolescents with otherwise unexplained neuropsychiatric manifestations. Early recognition and targeted treatment are crucial for improving long-term neurological outcomes.

Indexed as

Carrier ProteinsHomocystinuriaOxidoreductasesVitamin B 12 DeficiencyAdolescentFemaleHumansHydroxocobalaminVitamin B 12Carrier ProteinsHydroxocobalaminMMACHC protein, humanOxidoreductasesVitamin B 12Cobalamin C defectCombined methylmalonic acidemia and homocystinuriaLate-onsetMMACHCNeuropsychiatric manifestations

Identifiers

PMID42897485
PMCPMC13682142

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.